Wadsworth Center, NYSDOH, Griffin Laboratory, 5668 State Farm Road, Slingerlands, NY 12159, USA.
J Virol. 2011 Jan;85(1):357-65. doi: 10.1128/JVI.01694-10. Epub 2010 Oct 20.
Influenza A viruses are human and animal pathogens that cause morbidity and mortality, which range from mild to severe. The 2009 H1N1 pandemic was caused by the emergence of a reassortant H1N1 subtype (H1N1pdm) influenza A virus containing gene segments that originally circulated in human, avian, and swine virus reservoirs. The molecular determinants of replication and pathogenesis of H1N1pdm viruses in humans and other mammals are poorly understood. Therefore, we set out to elucidate viral determinants critical to the pathogenesis of this novel reassortant using a mouse model. We found that a glutamate-to-glycine substitution at residue 158 of the PB2 gene (PB2-E158G) increased the morbidity and mortality of the parental H1N1pdm virus. Results from mini-genome replication assays in human cells and virus titration in mouse tissues demonstrated that PB2-E158G is a pathogenic determinant, because it significantly increases viral replication rates. The virus load in PB2-E158G-infected mouse lungs was 1,300-fold higher than that of the wild-type virus. Our data also show that PB2-E158G had a much stronger influence on the RNA replication and pathogenesis of H1N1pdm viruses than PB2-E627K, which is a known pathogenic determinant. Remarkably, PB2-E158G substitutions also altered the pathotypes of two avian H5 viruses in mice, indicating that this residue impacts genetically divergent influenza A viruses and suggesting that this region of PB2 could be a new antiviral target. Collectively, the data presented in this study demonstrate that PB2-E158G is a novel pathogenic determinant of influenza A viruses in the mouse model. We speculate that PB2-E158G may be important in the adaptation of avian PB2 genes to other mammals, and BLAST sequence analysis identified a naturally occurring human H1N1pdm isolate that has this substitution. Therefore, future surveillance efforts should include scrutiny of this region of PB2 because of its potential impact on pathogenesis.
甲型流感病毒既是人类病原体也是动物病原体,可引起从轻度到重度的发病和死亡。2009 年的 H1N1 大流行是由一种重配的 H1N1 亚型(H1N1pdm)甲型流感病毒引起的,该病毒包含最初在人类、禽类和猪病毒库中循环的基因片段。H1N1pdm 病毒在人类和其他哺乳动物中的复制和发病机制的分子决定因素还了解甚少。因此,我们着手使用小鼠模型阐明与这种新型重配病毒发病机制相关的病毒决定因素。我们发现 PB2 基因(PB2-E158G)第 158 位的谷氨酸突变为甘氨酸增加了亲本 H1N1pdm 病毒的发病率和死亡率。在人细胞中的迷你基因组复制测定和在鼠组织中的病毒滴定结果表明,PB2-E158G 是一个致病决定因素,因为它显著增加了病毒的复制率。PB2-E158G 感染的鼠肺中的病毒载量比野生型病毒高 1300 倍。我们的数据还表明,PB2-E158G 对 H1N1pdm 病毒的 RNA 复制和发病机制的影响比已知的致病决定因素 PB2-E627K 大得多。值得注意的是,PB2-E158G 取代还改变了两种禽 H5 病毒在小鼠中的病原型,表明该残基影响遗传上不同的甲型流感病毒,并表明 PB2 的这一区域可能是新的抗病毒靶点。总的来说,本研究提供的数据表明,PB2-E158G 是小鼠模型中甲型流感病毒的一个新的致病决定因素。我们推测,PB2-E158G 在禽 PB2 基因适应其他哺乳动物方面可能很重要,BLAST 序列分析鉴定出具有此取代的天然发生的人 H1N1pdm 分离株。因此,未来的监测工作应包括对 PB2 这一区域的审查,因为它可能对发病机制产生影响。